178 related articles for article (PubMed ID: 22180778)
41. CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells.
Tarnowski M; Liu R; Wysoczynski M; Ratajczak J; Kucia M; Ratajczak MZ
Eur J Haematol; 2010 Dec; 85(6):472-83. PubMed ID: 20887389
[TBL] [Abstract][Full Text] [Related]
42. The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation.
Salazar N; Muñoz D; Kallifatidis G; Singh RK; Jordà M; Lokeshwar BL
Mol Cancer; 2014 Aug; 13():198. PubMed ID: 25168820
[TBL] [Abstract][Full Text] [Related]
43. Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.
Boudot A; Kerdivel G; Habauzit D; Eeckhoute J; Le Dily F; Flouriot G; Samson M; Pakdel F
PLoS One; 2011; 6(6):e20898. PubMed ID: 21695171
[TBL] [Abstract][Full Text] [Related]
44. CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis.
Moreno MJ; Gallardo A; Novelli S; Mozos A; Aragó M; Pavón MÁ; Céspedes MV; Pallarès V; Falgàs A; Alcoceba M; Blanco O; Gonzalez-Díaz M; Sierra J; Mangues R; Casanova I
PLoS One; 2018; 13(6):e0198789. PubMed ID: 29920526
[TBL] [Abstract][Full Text] [Related]
45. The involvement of CXCR7 in modulating the progression of papillary thyroid carcinoma.
Liu Z; Yang L; Teng X; Zhang H; Guan H
J Surg Res; 2014 Oct; 191(2):379-88. PubMed ID: 24814201
[TBL] [Abstract][Full Text] [Related]
46. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
Daniel SK; Seo YD; Pillarisetty VG
Semin Cancer Biol; 2020 Oct; 65():176-188. PubMed ID: 31874281
[TBL] [Abstract][Full Text] [Related]
47. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
[TBL] [Abstract][Full Text] [Related]
48. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
[TBL] [Abstract][Full Text] [Related]
49. The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth.
Singh RK; Lokeshwar BL
Cancer Res; 2011 May; 71(9):3268-77. PubMed ID: 21398406
[TBL] [Abstract][Full Text] [Related]
50. Computer-aided assessment of the chemokine receptors CXCR3, CXCR4 and CXCR7 expression in gallbladder carcinoma.
Yu X; Lu W; Ng CW; Xu S; Wu Y; Chen S; Gao Y; Zhang Y; Zhang Q; Xu Y; Liu Y; Li S
J Cell Mol Med; 2020 Jul; 24(13):7670-7674. PubMed ID: 32512633
[TBL] [Abstract][Full Text] [Related]
51. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
52. CXCR7 maintains osteosarcoma invasion after CXCR4 suppression in bone marrow microenvironment.
Han Y; Wu C; Wang J; Liu N
Tumour Biol; 2017 May; 39(5):1010428317701631. PubMed ID: 28468584
[TBL] [Abstract][Full Text] [Related]
53. MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4).
Visintin A; Halmen KA; Khan N; Monks BG; Golenbock DT; Lien E
J Leukoc Biol; 2006 Dec; 80(6):1584-92. PubMed ID: 16946018
[TBL] [Abstract][Full Text] [Related]
54. The role of the SDF-1/ CXCR7 axis on the growth and invasion ability of endometrial cancer cells.
Gu HQ; Zhang ZB; Zhang JW; Wang QQ; Xi XW; He YY
Arch Gynecol Obstet; 2017 Apr; 295(4):987-995. PubMed ID: 28239742
[TBL] [Abstract][Full Text] [Related]
55. High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma.
Wang L; Chen W; Gao L; Yang Q; Liu B; Wu Z; Wang Y; Sun Y
World J Surg Oncol; 2012 Oct; 10():212. PubMed ID: 23039915
[TBL] [Abstract][Full Text] [Related]
56. The expression and biological function of chemokine CXCL12 and receptor CXCR4/CXCR7 in placenta accreta spectrum disorders.
Long Y; Jiang Y; Zeng J; Dang Y; Chen Y; Lin J; Wei H; Xia H; Long J; Luo C; Chen Z; Huang Y; Li M
J Cell Mol Med; 2020 Mar; 24(5):3167-3182. PubMed ID: 31991051
[TBL] [Abstract][Full Text] [Related]
57. SDF-1/CXCR7 axis regulates the proliferation, invasion, adhesion, and angiogenesis of gastric cancer cells.
Ma DM; Luo DX; Zhang J
World J Surg Oncol; 2016 Oct; 14(1):256. PubMed ID: 27716367
[TBL] [Abstract][Full Text] [Related]
58. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
[No Abstract] [Full Text] [Related]
59. CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration.
Décaillot FM; Kazmi MA; Lin Y; Ray-Saha S; Sakmar TP; Sachdev P
J Biol Chem; 2011 Sep; 286(37):32188-97. PubMed ID: 21730065
[TBL] [Abstract][Full Text] [Related]
60. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
